Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 72, 2008 - Issue 6
Journal homepage
208
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

Effects of the Antlered Form of Ganoderma lucidum on Tumor Growth and Metastasis in Cyclophosphamide-Treated Mice

Yuji NONAKAInstitute for Health Care Science, Suntory Ltd.
,
Hiroko ISHIBASHIInstitute of Medical Mycology, Teikyo University
,
Masaaki NAKAIInstitute for Health Care Science, Suntory Ltd.
,
Hiroshi SHIBATAInstitute for Health Care Science, Suntory Ltd.
,
Yoshinobu KISOInstitute for Health Care Science, Suntory Ltd.
&
Shigeru ABEInstitute of Medical Mycology, Teikyo University
Pages 1399-1408 | Received 25 Sep 2007, Accepted 31 Jan 2008, Published online: 22 May 2014

  • 1) Allison, A. C., Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology, 47, 63–83 (2000).
  • 2) Tsung, K., Meko, J. B., Tsung, Y. L., Peplinski, G. R., and Norton, J. A., Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12. J. Immunol., 160, 1369–1377 (1998).
  • 3) Karnbach, C., Daws, M. R., Niemi, E. C., and Nakamura, M. C., Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population. J. Immunol., 167, 2569–2576 (2001).
  • 4) Chapoval, A. I., Fuller, J. A., Kremlev, S. G., Kamdar, S. J., and Evans, R., Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. J. Immunol., 161, 6977–6984 (1998).
  • 5) Goldfarb, R. H., Ohashi, M., Brunson, K. W., Kirii, Y., Kotera, Y., Basse, P. H., and Kitson, R. P., Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide. Anticancer Res., 18, 1441–1446 (1998).
  • 6) Hamuro, J., Kikuchi, T., Takatsuki, F., and Suzuki, M., Cancer cell progression and chemoimmunotherapy-dual effects in the induction of resistance to therapy. Br. J. Cancer, 73, 465–471 (1996).
  • 7) Harada, T., Miura, N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N., Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol. Pharm. Bull., 25, 931–939 (2002).
  • 8) Harada, T., Kawaminami, H., Miura, N. N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N., Mechanism of enhanced hematopoietic response by soluble β-glucan SCG in cyclophosphamide-treated mice. Microbiol. Immunol., 50, 687–700 (2006).
  • 9) Zhang, L., Zhang, M., Zhou, Q., Chen, J., and Zeng, F., Solution properties of antitumor sulfated derivative of α-(1→3)-D-glucan from Ganoderma lucidum. Biosci. Biotechnol. Biochem., 64, 2172–2178 (2000).
  • 10) Wang, Y. Y., Khoo, K. H., Chen, S. T., Lin, C. C., Wong, C. H., and Lin, C. H., Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg. Med. Chem., 10, 1057–1062 (2002).
  • 11) Kim, D. H., Shim, S. B., Kim, N. J., and Jang, I. S., β-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol. Pharm. Bull., 22, 162–164 (1999).
  • 12) Sone, Y., Okuda, R., Wada, N., Kishida, E., and Misaki, A., Structures and antitumor activity of the polysaccharides isolated from fruiting body and growing culture of mycelium of Ganoderma lucidum. Agric. Biol. Chem., 49, 2641–2653 (1985).
  • 13) Tasaka, K., Akagi, M., Miyoshi, K., Mio, M., and Makino, T., Anti-allergic constituents in the culture medium of Ganoderma lucidum. I. Inhibitory effect of oleic acid on histamine release. Agents Actions, 23, 153–156 (1988).
  • 14) Tasaka, K., Mio, M., Izushi, K., Akagi, M., and Makino, T., Anti-allergic constituents in the culture medium of Ganoderma lucidum. II. The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions, 23, 157–160 (1988).
  • 15) Nonaka, Y., Shibata, H., Nakai, M., Kurihara, H., Ishibashi, H., Kiso, Y., Tanaka, T., Yamaguchi, H., and Abe, S., Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci. Biotechnol. Biochem., 70, 2028–2034 (2006).
  • 16) Kohguchi, M., Kunikata, T., Watanabe, H., Kudo, N., Shibuya, T., Ishihara, T., Iwaki, K., Ikeda, M., Fukuda, S., and Kurimoto, M., Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi). Biosci. Biotechnol. Biochem., 68, 881–887 (2004).
  • 17) Masuko, Y., Nakajima, H., Tsubouchi, J., Yamazaki, M., Mizuno, D., and Abe, S., Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction. Gann, 73, 790–797 (1982).
  • 18) Kodama, N., Komuta, K., Sakai, N., and Nanba, H., Effects of D-fraction, a polysaccharide from Grifola frondosa, on tumor growth involve activation of NK cells. Biol. Pharm. Bull., 25, 1647–1650 (2002).
  • 19) Czop, J. K., and Austen, K. F., Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J. Immunol., 135, 3388–3393 (1985).
  • 20) Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D., Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 156, 1235–1246 (1996).
  • 21) Taylor, P. R., Brown, G. D., Reid, D. M., Willment, J. A., Martinez-Pomares, L., Gordon, S., and Wong, S. Y., The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol., 169, 3876–3882 (2002).
  • 22) Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S., and Gordon, S., Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med., 197, 1119–1124 (2003).
  • 23) Takeda, K., Kaisho, T., and Akira, S., Toll-like receptors. Annu. Rev. Immunol., 21, 335–376 (2003).
  • 24) D’Agostini, C., Pica, F., Febbraro, G., Grelli, S., Chiavaroli, C., and Garaci, E., Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions. Int. Immunopharmacol., 5, 1205–1212 (2005).
  • 25) Hong, F., Yan, J., Baran, J. T., Allendorf, D. J., Hansen, R. D., Ostroff, G. R., Xing, P. X., Cheung, N. K., and Ross, G. D., Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol., 173, 797–806 (2004).
  • 26) Hong, F., Hansen, R. D., Yan, J., Allendorf, D. J., Baran, J. T., Ostroff, G. R., and Ross, G. D., β-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res., 63, 9023–9031 (2003).
  • 27) Vetvicka, V., Dvorak, B., Vetvickova, J., Richter, J., Krizan, J., Sima, P., and Yvin, J. C., Orally administered marine (1→3)-β-D-glucan phycarine stimulates both humoral and cellular immunity. Int. J. Biol. Macromol., 40, 291–298 (2007).
  • 28) Inomata, T., Goodman, G. B., Fryer, C. J., Chaplin, D. J., Palcic, B., Lam, G. K., Nishioka, A., and Ogawa, Y., Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG). Br. J. Cancer Suppl., 27, 122–125 (1996).
  • 29) Kimura, Y., Taniguchi, M., and Baba, K., Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res., 22, 3309–3318 (2002).
  • 30) Wang, G., Zhao, J., Liu, J., Huang, Y., Zhong, J. J., and Tang, W., Enhancement of IL-2 and IFN-γ expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int. Immunopharmacol., 7, 864–870 (2007).
  • 31) Min, B. S., Nakamura, N., Miyashiro, H., Bae, K. W., and Hattori, M., Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull., 46, 1607–1612 (1998).
  • 32) Lin, Z. B., Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J. Pharmacol. Sci., 99, 144–153 (2005).
  • 33) Thyagarajan, A., Jiang, J., Hopf, A., Adamec, J., and Sliva, D., Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int. J. Mol. Med., 18, 657–664 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.